Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
PIK3CA [1] PIK3CA 💬Acute myeloid leukemia
|
Alpelisib Alpelisib 💬Acute myeloid leukemia
| Alpelisib | 138 [4] 138, 278, 279, 280 💬1. Acute myeloid leukemia
|
||||||||||||||||||
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA [1] PIK3CA 💬AGE-RAGE signaling pathway in diabetic complications
|
Alpelisib Alpelisib 💬AGE-RAGE signaling pathway in diabetic complications
| Alpelisib | 138 [4] 138, 278, 279, 280 💬2. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
| 3 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
PIK3CA [1] PIK3CA 💬Aldosterone-regulated sodium reabsorption
|
Alpelisib Alpelisib 💬Aldosterone-regulated sodium reabsorption
| Alpelisib | 138 [4] 138, 278, 279, 280 💬3. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PIK3CA [1] PIK3CA 💬Alzheimer disease
|
Alpelisib Alpelisib 💬Alzheimer disease
| Alpelisib | 138 [4] 138, 278, 279, 280 💬4. Alzheimer disease
|
||||||||||||||||||
| 5 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
PIK3CA [1] PIK3CA 💬Amoebiasis
|
Alpelisib Alpelisib 💬Amoebiasis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬5. Amoebiasis
|
||||||||||||||||||
| 6 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA [1] PIK3CA 💬AMPK signaling pathway
|
Alpelisib Alpelisib 💬AMPK signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬6. AMPK signaling pathway
|
||||||||||||||||||
| 7 | Apoptosis 💬 18 genes, 32 drugs (DrugBank) and 68 diseases |
PIK3CA [1] PIK3CA 💬Apoptosis
|
Alpelisib Alpelisib 💬Apoptosis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬7. Apoptosis
|
||||||||||||||||||
| 8 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
PIK3CA [1] PIK3CA 💬Autophagy - animal
|
Alpelisib Alpelisib 💬Autophagy - animal
| Alpelisib | 138 [4] 138, 278, 279, 280 💬8. Autophagy - animal
|
||||||||||||||||||
| 9 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 73 diseases |
PIK3CA [1] PIK3CA 💬Axon guidance
|
Alpelisib Alpelisib 💬Axon guidance
| Alpelisib | 138 [4] 138, 278, 279, 280 💬9. Axon guidance
|
||||||||||||||||||
| 10 | B cell receptor signaling pathway 💬 19 genes, 38 drugs (DrugBank) and 68 diseases |
PIK3CA [1] PIK3CA 💬B cell receptor signaling pathway
|
Alpelisib Alpelisib 💬B cell receptor signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬10. B cell receptor signaling pathway
|
||||||||||||||||||
| 11 | Bacterial invasion of epithelial cells 💬 7 genes, 10 drugs (DrugBank) and 24 diseases |
PIK3CA [1] PIK3CA 💬Bacterial invasion of epithelial cells
|
Alpelisib Alpelisib 💬Bacterial invasion of epithelial cells
| Alpelisib | 138 [4] 138, 278, 279, 280 💬11. Bacterial invasion of epithelial cells
|
||||||||||||||||||
| 12 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
PIK3CA [1] PIK3CA 💬Breast cancer
|
Alpelisib Alpelisib 💬Breast cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬12. Breast cancer
|
||||||||||||||||||
| 13 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PIK3CA [1] PIK3CA 💬C-type lectin receptor signaling pathway
|
Alpelisib Alpelisib 💬C-type lectin receptor signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬13. C-type lectin receptor signaling pathway
|
||||||||||||||||||
| 14 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PIK3CA [1] PIK3CA 💬cAMP signaling pathway
|
Alpelisib Alpelisib 💬cAMP signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬14. cAMP signaling pathway
|
||||||||||||||||||
| 15 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
PIK3CA [1] PIK3CA 💬Carbohydrate digestion and absorption
|
Alpelisib Alpelisib 💬Carbohydrate digestion and absorption
| Alpelisib | 138 [4] 138, 278, 279, 280 💬15. Carbohydrate digestion and absorption
|
||||||||||||||||||
| 16 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
PIK3CA [1] PIK3CA 💬Cellular senescence
|
Alpelisib Alpelisib 💬Cellular senescence
| Alpelisib | 138 [4] 138, 278, 279, 280 💬16. Cellular senescence
|
||||||||||||||||||
| 17 | Central carbon metabolism in cancer 💬 20 genes, 37 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Central carbon metabolism in cancer
|
Alpelisib Alpelisib 💬Central carbon metabolism in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬17. Central carbon metabolism in cancer
|
||||||||||||||||||
| 18 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
PIK3CA [1] PIK3CA 💬Chagas disease
|
Alpelisib Alpelisib 💬Chagas disease
| Alpelisib | 138 [4] 138, 278, 279, 280 💬18. Chagas disease
|
||||||||||||||||||
| 19 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
PIK3CA [1] PIK3CA 💬Chemical carcinogenesis - reactive oxygen species
|
Alpelisib Alpelisib 💬Chemical carcinogenesis - reactive oxygen species
| Alpelisib | 138 [4] 138, 278, 279, 280 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||
| 20 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
PIK3CA [1] PIK3CA 💬Chemical carcinogenesis - receptor activation
|
Alpelisib Alpelisib 💬Chemical carcinogenesis - receptor activation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬20. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||
| 21 | Chemokine signaling pathway 💬 25 genes, 38 drugs (DrugBank) and 66 diseases |
PIK3CA [1] PIK3CA 💬Chemokine signaling pathway
|
Alpelisib Alpelisib 💬Chemokine signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬21. Chemokine signaling pathway
|
||||||||||||||||||
| 22 | Choline metabolism in cancer 💬 11 genes, 29 drugs (DrugBank) and 64 diseases |
PIK3CA [1] PIK3CA 💬Choline metabolism in cancer
|
Alpelisib Alpelisib 💬Choline metabolism in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬22. Choline metabolism in cancer
|
||||||||||||||||||
| 23 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
PIK3CA [1] PIK3CA 💬Cholinergic synapse
|
Alpelisib Alpelisib 💬Cholinergic synapse
| Alpelisib | 138 [4] 138, 278, 279, 280 💬23. Cholinergic synapse
|
||||||||||||||||||
| 24 | Chronic myeloid leukemia 💬 18 genes, 23 drugs (DrugBank) and 39 diseases |
PIK3CA [1] PIK3CA 💬Chronic myeloid leukemia
|
Alpelisib Alpelisib 💬Chronic myeloid leukemia
| Alpelisib | 138 [4] 138, 278, 279, 280 💬24. Chronic myeloid leukemia
|
||||||||||||||||||
| 25 | Colorectal cancer 💬 15 genes, 27 drugs (DrugBank) and 62 diseases |
PIK3CA [1] PIK3CA 💬Colorectal cancer
|
Alpelisib Alpelisib 💬Colorectal cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬25. Colorectal cancer
|
||||||||||||||||||
| 26 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
PIK3CA [1] PIK3CA 💬Coronavirus disease
|
Alpelisib Alpelisib 💬Coronavirus disease
| Alpelisib | 138 [4] 138, 278, 279, 280 💬26. Coronavirus disease
|
||||||||||||||||||
| 27 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
PIK3CA [1] PIK3CA 💬Diabetic cardiomyopathy
|
Alpelisib Alpelisib 💬Diabetic cardiomyopathy
| Alpelisib | 138 [4] 138, 278, 279, 280 💬27. Diabetic cardiomyopathy
|
||||||||||||||||||
| 28 | Endometrial cancer 💬 10 genes, 19 drugs (DrugBank) and 28 diseases |
PIK3CA [1] PIK3CA 💬Endometrial cancer
|
Alpelisib Alpelisib 💬Endometrial cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬28. Endometrial cancer
|
||||||||||||||||||
| 29 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
PIK3CA [1] PIK3CA 💬Epstein-Barr virus infection
|
Alpelisib Alpelisib 💬Epstein-Barr virus infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬29. Epstein-Barr virus infection
|
||||||||||||||||||
| 30 | ErbB signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
PIK3CA [1] PIK3CA 💬ErbB signaling pathway
|
Alpelisib Alpelisib 💬ErbB signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬30. ErbB signaling pathway
|
||||||||||||||||||
| 31 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Estrogen signaling pathway
|
Alpelisib Alpelisib 💬Estrogen signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬31. Estrogen signaling pathway
|
||||||||||||||||||
| 32 | Fc epsilon RI signaling pathway 💬 19 genes, 49 drugs (DrugBank) and 71 diseases |
PIK3CA [1] PIK3CA 💬Fc epsilon RI signaling pathway
|
Alpelisib Alpelisib 💬Fc epsilon RI signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬32. Fc epsilon RI signaling pathway
|
||||||||||||||||||
| 33 | Fc gamma R-mediated phagosome formation 💬 9 genes, 13 drugs (DrugBank) and 20 diseases |
PIK3CA [1] PIK3CA 💬Fc gamma R-mediated phagosome formation
|
Alpelisib Alpelisib 💬Fc gamma R-mediated phagosome formation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬33. Fc gamma R-mediated phagosome formation
|
||||||||||||||||||
| 34 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
PIK3CA [1] PIK3CA 💬Fluid shear stress and atherosclerosis
|
Alpelisib Alpelisib 💬Fluid shear stress and atherosclerosis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬34. Fluid shear stress and atherosclerosis
|
||||||||||||||||||
| 35 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
PIK3CA [1] PIK3CA 💬Focal adhesion
|
Alpelisib Alpelisib 💬Focal adhesion
| Alpelisib | 138 [4] 138, 278, 279, 280 💬35. Focal adhesion
|
||||||||||||||||||
| 36 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
PIK3CA [1] PIK3CA 💬FoxO signaling pathway
|
Alpelisib Alpelisib 💬FoxO signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬36. FoxO signaling pathway
|
||||||||||||||||||
| 37 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
PIK3CA [1] PIK3CA 💬Gastric cancer
|
Alpelisib Alpelisib 💬Gastric cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬37. Gastric cancer
|
||||||||||||||||||
| 38 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
PIK3CA [1] PIK3CA 💬Glioma
|
Alpelisib Alpelisib 💬Glioma
| Alpelisib | 138 [4] 138, 278, 279, 280 💬38. Glioma
|
||||||||||||||||||
| 39 | GnRH secretion 💬 27 genes, 49 drugs (DrugBank) and 62 diseases |
PIK3CA [1] PIK3CA 💬GnRH secretion
|
Alpelisib Alpelisib 💬GnRH secretion
| Alpelisib | 138 [4] 138, 278, 279, 280 💬39. GnRH secretion
|
||||||||||||||||||
| 40 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
PIK3CA [1] PIK3CA 💬Growth hormone synthesis, secretion and action
|
Alpelisib Alpelisib 💬Growth hormone synthesis, secretion and action
| Alpelisib | 138 [4] 138, 278, 279, 280 💬40. Growth hormone synthesis, secretion and action
|
||||||||||||||||||
| 41 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
PIK3CA [1] PIK3CA 💬Hepatitis B
|
Alpelisib Alpelisib 💬Hepatitis B
| Alpelisib | 138 [4] 138, 278, 279, 280 💬41. Hepatitis B
|
||||||||||||||||||
| 42 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
PIK3CA [1] PIK3CA 💬Hepatitis C
|
Alpelisib Alpelisib 💬Hepatitis C
| Alpelisib | 138 [4] 138, 278, 279, 280 💬42. Hepatitis C
|
||||||||||||||||||
| 43 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Hepatocellular carcinoma
|
Alpelisib Alpelisib 💬Hepatocellular carcinoma
| Alpelisib | 138 [4] 138, 278, 279, 280 💬43. Hepatocellular carcinoma
|
||||||||||||||||||
| 44 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
PIK3CA [1] PIK3CA 💬Herpes simplex virus 1 infection
|
Alpelisib Alpelisib 💬Herpes simplex virus 1 infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬44. Herpes simplex virus 1 infection
|
||||||||||||||||||
| 45 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA [1] PIK3CA 💬HIF-1 signaling pathway
|
Alpelisib Alpelisib 💬HIF-1 signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬45. HIF-1 signaling pathway
|
||||||||||||||||||
| 46 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PIK3CA [1] PIK3CA 💬Hormone signaling
|
Alpelisib Alpelisib 💬Hormone signaling
| Alpelisib | 138 [4] 138, 278, 279, 280 💬46. Hormone signaling
|
||||||||||||||||||
| 47 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PIK3CA [1] PIK3CA 💬Human cytomegalovirus infection
|
Alpelisib Alpelisib 💬Human cytomegalovirus infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬47. Human cytomegalovirus infection
|
||||||||||||||||||
| 48 | Human immunodeficiency virus 1 infection 💬 51 genes, 59 drugs (DrugBank) and 98 diseases |
PIK3CA [1] PIK3CA 💬Human immunodeficiency virus 1 infection
|
Alpelisib Alpelisib 💬Human immunodeficiency virus 1 infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬48. Human immunodeficiency virus 1 infection
|
||||||||||||||||||
| 49 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PIK3CA [1] PIK3CA 💬Human papillomavirus infection
|
Alpelisib Alpelisib 💬Human papillomavirus infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬49. Human papillomavirus infection
|
||||||||||||||||||
| 50 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
PIK3CA [1] PIK3CA 💬Human T-cell leukemia virus 1 infection
|
Alpelisib Alpelisib 💬Human T-cell leukemia virus 1 infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬50. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||
| 51 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
PIK3CA [1] PIK3CA 💬IgSF CAM signaling
|
Alpelisib Alpelisib 💬IgSF CAM signaling
| Alpelisib | 138 [4] 138, 278, 279, 280 💬51. IgSF CAM signaling
|
||||||||||||||||||
| 52 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Inflammatory mediator regulation of TRP channels
|
Alpelisib Alpelisib 💬Inflammatory mediator regulation of TRP channels
| Alpelisib | 138 [4] 138, 278, 279, 280 💬52. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||
| 53 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
PIK3CA [1] PIK3CA 💬Influenza A
|
Alpelisib Alpelisib 💬Influenza A
| Alpelisib | 138 [4] 138, 278, 279, 280 💬53. Influenza A
|
||||||||||||||||||
| 54 | Inositol phosphate metabolism 💬 4 genes, 5 drugs (DrugBank) and 10 diseases |
PIK3CA [1] PIK3CA 💬Inositol phosphate metabolism
|
Alpelisib Alpelisib 💬Inositol phosphate metabolism
| Alpelisib | 138 [4] 138, 278, 279, 280 💬54. Inositol phosphate metabolism
|
||||||||||||||||||
| 55 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PIK3CA [1] PIK3CA 💬Insulin resistance
|
Alpelisib Alpelisib 💬Insulin resistance
| Alpelisib | 138 [4] 138, 278, 279, 280 💬55. Insulin resistance
|
||||||||||||||||||
| 56 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PIK3CA [1] PIK3CA 💬Insulin signaling pathway
|
Alpelisib Alpelisib 💬Insulin signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬56. Insulin signaling pathway
|
||||||||||||||||||
| 57 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
PIK3CA [1] PIK3CA 💬Integrin signaling
|
Alpelisib Alpelisib 💬Integrin signaling
| Alpelisib | 138 [4] 138, 278, 279, 280 💬57. Integrin signaling
|
||||||||||||||||||
| 58 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
PIK3CA [1] PIK3CA 💬JAK-STAT signaling pathway
|
Alpelisib Alpelisib 💬JAK-STAT signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬58. JAK-STAT signaling pathway
|
||||||||||||||||||
| 59 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PIK3CA [1] PIK3CA 💬Kaposi sarcoma-associated herpesvirus infection
|
Alpelisib Alpelisib 💬Kaposi sarcoma-associated herpesvirus infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬59. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||
| 60 | Leukocyte transendothelial migration 💬 19 genes, 23 drugs (DrugBank) and 37 diseases |
PIK3CA [1] PIK3CA 💬Leukocyte transendothelial migration
|
Alpelisib Alpelisib 💬Leukocyte transendothelial migration
| Alpelisib | 138 [4] 138, 278, 279, 280 💬60. Leukocyte transendothelial migration
|
||||||||||||||||||
| 61 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PIK3CA [1] PIK3CA 💬Lipid and atherosclerosis
|
Alpelisib Alpelisib 💬Lipid and atherosclerosis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬61. Lipid and atherosclerosis
|
||||||||||||||||||
| 62 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PIK3CA [1] PIK3CA 💬Longevity regulating pathway
|
Alpelisib Alpelisib 💬Longevity regulating pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬62. Longevity regulating pathway
|
||||||||||||||||||
| 63 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Longevity regulating pathway - multiple species
|
Alpelisib Alpelisib 💬Longevity regulating pathway - multiple species
| Alpelisib | 138 [4] 138, 278, 279, 280 💬63. Longevity regulating pathway - multiple species
|
||||||||||||||||||
| 64 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
PIK3CA [1] PIK3CA 💬Measles
|
Alpelisib Alpelisib 💬Measles
| Alpelisib | 138 [4] 138, 278, 279, 280 💬64. Measles
|
||||||||||||||||||
| 65 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
PIK3CA [1] PIK3CA 💬Melanoma
|
Alpelisib Alpelisib 💬Melanoma
| Alpelisib | 138 [4] 138, 278, 279, 280 💬65. Melanoma
|
||||||||||||||||||
| 66 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PIK3CA [1] PIK3CA 💬MicroRNAs in cancer
|
Alpelisib Alpelisib 💬MicroRNAs in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬66. MicroRNAs in cancer
|
||||||||||||||||||
| 67 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
PIK3CA [1] PIK3CA 💬mTOR signaling pathway
|
Alpelisib Alpelisib 💬mTOR signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬67. mTOR signaling pathway
|
||||||||||||||||||
| 68 | Natural killer cell mediated cytotoxicity 💬 45 genes, 49 drugs (DrugBank) and 91 diseases |
PIK3CA [1] PIK3CA 💬Natural killer cell mediated cytotoxicity
|
Alpelisib Alpelisib 💬Natural killer cell mediated cytotoxicity
| Alpelisib | 138 [4] 138, 278, 279, 280 💬68. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||
| 69 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 38 diseases |
PIK3CA [1] PIK3CA 💬Neurotrophin signaling pathway
|
Alpelisib Alpelisib 💬Neurotrophin signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬69. Neurotrophin signaling pathway
|
||||||||||||||||||
| 70 | Neutrophil extracellular trap formation 💬 37 genes, 45 drugs (DrugBank) and 78 diseases |
PIK3CA [1] PIK3CA 💬Neutrophil extracellular trap formation
|
Alpelisib Alpelisib 💬Neutrophil extracellular trap formation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬70. Neutrophil extracellular trap formation
|
||||||||||||||||||
| 71 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PIK3CA [1] PIK3CA 💬Non-alcoholic fatty liver disease
|
Alpelisib Alpelisib 💬Non-alcoholic fatty liver disease
| Alpelisib | 138 [4] 138, 278, 279, 280 💬71. Non-alcoholic fatty liver disease
|
||||||||||||||||||
| 72 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
PIK3CA [1] PIK3CA 💬Non-small cell lung cancer
|
Alpelisib Alpelisib 💬Non-small cell lung cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬72. Non-small cell lung cancer
|
||||||||||||||||||
| 73 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PIK3CA [1] PIK3CA 💬Osteoclast differentiation
|
Alpelisib Alpelisib 💬Osteoclast differentiation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬73. Osteoclast differentiation
|
||||||||||||||||||
| 74 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
PIK3CA [1] PIK3CA 💬Pancreatic cancer
|
Alpelisib Alpelisib 💬Pancreatic cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬74. Pancreatic cancer
|
||||||||||||||||||
| 75 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PIK3CA [1] PIK3CA 💬Pathways in cancer
|
Alpelisib Alpelisib 💬Pathways in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬75. Pathways in cancer
|
||||||||||||||||||
| 76 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
PIK3CA [1] PIK3CA 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Alpelisib Alpelisib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬76. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||
| 77 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
PIK3CA [1] PIK3CA 💬Phagocytosis
|
Alpelisib Alpelisib 💬Phagocytosis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬77. Phagocytosis
|
||||||||||||||||||
| 78 | Phosphatidylinositol signaling system 💬 5 genes, 6 drugs (DrugBank) and 11 diseases |
PIK3CA [1] PIK3CA 💬Phosphatidylinositol signaling system
|
Alpelisib Alpelisib 💬Phosphatidylinositol signaling system
| Alpelisib | 138 [4] 138, 278, 279, 280 💬78. Phosphatidylinositol signaling system
|
||||||||||||||||||
| 79 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
PIK3CA [1] PIK3CA 💬Phospholipase D signaling pathway
|
Alpelisib Alpelisib 💬Phospholipase D signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬79. Phospholipase D signaling pathway
|
||||||||||||||||||
| 80 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PIK3CA [1] PIK3CA 💬PI3K-Akt signaling pathway
|
Alpelisib Alpelisib 💬PI3K-Akt signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬80. PI3K-Akt signaling pathway
|
||||||||||||||||||
| 81 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PIK3CA [1] PIK3CA 💬Platelet activation
|
Alpelisib Alpelisib 💬Platelet activation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬81. Platelet activation
|
||||||||||||||||||
| 82 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
PIK3CA [1] PIK3CA 💬Prion disease
|
Alpelisib Alpelisib 💬Prion disease
| Alpelisib | 138 [4] 138, 278, 279, 280 💬82. Prion disease
|
||||||||||||||||||
| 83 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PIK3CA [1] PIK3CA 💬Progesterone-mediated oocyte maturation
|
Alpelisib Alpelisib 💬Progesterone-mediated oocyte maturation
| Alpelisib | 138 [4] 138, 278, 279, 280 💬83. Progesterone-mediated oocyte maturation
|
||||||||||||||||||
| 84 | Prolactin signaling pathway 💬 20 genes, 44 drugs (DrugBank) and 74 diseases |
PIK3CA [1] PIK3CA 💬Prolactin signaling pathway
|
Alpelisib Alpelisib 💬Prolactin signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬84. Prolactin signaling pathway
|
||||||||||||||||||
| 85 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
PIK3CA [1] PIK3CA 💬Prostate cancer
|
Alpelisib Alpelisib 💬Prostate cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬85. Prostate cancer
|
||||||||||||||||||
| 86 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
PIK3CA [1] PIK3CA 💬Proteoglycans in cancer
|
Alpelisib Alpelisib 💬Proteoglycans in cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬86. Proteoglycans in cancer
|
||||||||||||||||||
| 87 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
PIK3CA [1] PIK3CA 💬Rap1 signaling pathway
|
Alpelisib Alpelisib 💬Rap1 signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬87. Rap1 signaling pathway
|
||||||||||||||||||
| 88 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
PIK3CA [1] PIK3CA 💬Ras signaling pathway
|
Alpelisib Alpelisib 💬Ras signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬88. Ras signaling pathway
|
||||||||||||||||||
| 89 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
PIK3CA [1] PIK3CA 💬Regulation of actin cytoskeleton
|
Alpelisib Alpelisib 💬Regulation of actin cytoskeleton
| Alpelisib | 138 [4] 138, 278, 279, 280 💬89. Regulation of actin cytoskeleton
|
||||||||||||||||||
| 90 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PIK3CA [1] PIK3CA 💬Regulation of lipolysis in adipocytes
|
Alpelisib Alpelisib 💬Regulation of lipolysis in adipocytes
| Alpelisib | 138 [4] 138, 278, 279, 280 💬90. Regulation of lipolysis in adipocytes
|
||||||||||||||||||
| 91 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
PIK3CA [1] PIK3CA 💬Relaxin signaling pathway
|
Alpelisib Alpelisib 💬Relaxin signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬91. Relaxin signaling pathway
|
||||||||||||||||||
| 92 | Renal cell carcinoma 💬 15 genes, 16 drugs (DrugBank) and 32 diseases |
PIK3CA [1] PIK3CA 💬Renal cell carcinoma
|
Alpelisib Alpelisib 💬Renal cell carcinoma
| Alpelisib | 138 [4] 138, 278, 279, 280 💬92. Renal cell carcinoma
|
||||||||||||||||||
| 93 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
PIK3CA [1] PIK3CA 💬Salmonella infection
|
Alpelisib Alpelisib 💬Salmonella infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬93. Salmonella infection
|
||||||||||||||||||
| 94 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
PIK3CA [1] PIK3CA 💬Shigellosis
|
Alpelisib Alpelisib 💬Shigellosis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬94. Shigellosis
|
||||||||||||||||||
| 95 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
PIK3CA [1] PIK3CA 💬Signaling pathways regulating pluripotency of stem cells
|
Alpelisib Alpelisib 💬Signaling pathways regulating pluripotency of stem cells
| Alpelisib | 138 [4] 138, 278, 279, 280 💬95. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||
| 96 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PIK3CA [1] PIK3CA 💬Small cell lung cancer
|
Alpelisib Alpelisib 💬Small cell lung cancer
| Alpelisib | 138 [4] 138, 278, 279, 280 💬96. Small cell lung cancer
|
||||||||||||||||||
| 97 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
PIK3CA [1] PIK3CA 💬Sphingolipid signaling pathway
|
Alpelisib Alpelisib 💬Sphingolipid signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬97. Sphingolipid signaling pathway
|
||||||||||||||||||
| 98 | Spinocerebellar ataxia 💬 18 genes, 30 drugs (DrugBank) and 79 diseases |
PIK3CA [1] PIK3CA 💬Spinocerebellar ataxia
|
Alpelisib Alpelisib 💬Spinocerebellar ataxia
| Alpelisib | 138 [4] 138, 278, 279, 280 💬98. Spinocerebellar ataxia
|
||||||||||||||||||
| 99 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
PIK3CA [1] PIK3CA 💬T cell receptor signaling pathway
|
Alpelisib Alpelisib 💬T cell receptor signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬99. T cell receptor signaling pathway
|
||||||||||||||||||
| 100 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
PIK3CA [1] PIK3CA 💬Thyroid hormone signaling pathway
|
Alpelisib Alpelisib 💬Thyroid hormone signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬100. Thyroid hormone signaling pathway
|
||||||||||||||||||
| 101 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PIK3CA [1] PIK3CA 💬TNF signaling pathway
|
Alpelisib Alpelisib 💬TNF signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬101. TNF signaling pathway
|
||||||||||||||||||
| 102 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
PIK3CA [1] PIK3CA 💬Toll-like receptor signaling pathway
|
Alpelisib Alpelisib 💬Toll-like receptor signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬102. Toll-like receptor signaling pathway
|
||||||||||||||||||
| 103 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
PIK3CA [1] PIK3CA 💬Type II diabetes mellitus
|
Alpelisib Alpelisib 💬Type II diabetes mellitus
| Alpelisib | 138 [4] 138, 278, 279, 280 💬103. Type II diabetes mellitus
|
||||||||||||||||||
| 104 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PIK3CA [1] PIK3CA 💬VEGF signaling pathway
|
Alpelisib Alpelisib 💬VEGF signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬104. VEGF signaling pathway
|
||||||||||||||||||
| 105 | Viral carcinogenesis 💬 32 genes, 34 drugs (DrugBank) and 60 diseases |
PIK3CA [1] PIK3CA 💬Viral carcinogenesis
|
Alpelisib Alpelisib 💬Viral carcinogenesis
| Alpelisib | 138 [4] 138, 278, 279, 280 💬105. Viral carcinogenesis
|
||||||||||||||||||
| 106 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
PIK3CA [1] PIK3CA 💬Yersinia infection
|
Alpelisib Alpelisib 💬Yersinia infection
| Alpelisib | 138 [4] 138, 278, 279, 280 💬106. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 77 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Apoptosis
18 genes, 32 drugs (DrugBank) and 68 diseases
Autophagy - animal
14 genes, 21 drugs (DrugBank) and 71 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 73 diseases
B cell receptor signaling pathway
19 genes, 38 drugs (DrugBank) and 68 diseases
Bacterial invasion of epithelial cells
7 genes, 10 drugs (DrugBank) and 24 diseases
Breast cancer
22 genes, 64 drugs (DrugBank) and 84 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
Central carbon metabolism in cancer
20 genes, 37 drugs (DrugBank) and 70 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Chemokine signaling pathway
25 genes, 38 drugs (DrugBank) and 66 diseases
Choline metabolism in cancer
11 genes, 29 drugs (DrugBank) and 64 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Chronic myeloid leukemia
18 genes, 23 drugs (DrugBank) and 39 diseases
Colorectal cancer
15 genes, 27 drugs (DrugBank) and 62 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Endometrial cancer
10 genes, 19 drugs (DrugBank) and 28 diseases
Epstein-Barr virus infection
67 genes, 97 drugs (DrugBank) and 83 diseases
ErbB signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Fc epsilon RI signaling pathway
19 genes, 49 drugs (DrugBank) and 71 diseases
Fc gamma R-mediated phagosome formation
9 genes, 13 drugs (DrugBank) and 20 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Focal adhesion
31 genes, 52 drugs (DrugBank) and 54 diseases
FoxO signaling pathway
26 genes, 43 drugs (DrugBank) and 62 diseases
Gastric cancer
23 genes, 41 drugs (DrugBank) and 69 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 67 diseases
GnRH secretion
27 genes, 49 drugs (DrugBank) and 62 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 97 diseases
Hepatitis B
44 genes, 70 drugs (DrugBank) and 92 diseases
Hepatitis C
37 genes, 75 drugs (DrugBank) and 92 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human immunodeficiency virus 1 infection
51 genes, 59 drugs (DrugBank) and 98 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
Inflammatory mediator regulation of TRP channels
26 genes, 55 drugs (DrugBank) and 70 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Inositol phosphate metabolism
4 genes, 5 drugs (DrugBank) and 10 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 104 diseases
Insulin signaling pathway
13 genes, 28 drugs (DrugBank) and 74 diseases
Integrin signaling
28 genes, 48 drugs (DrugBank) and 77 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leukocyte transendothelial migration
19 genes, 23 drugs (DrugBank) and 37 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Longevity regulating pathway
11 genes, 23 drugs (DrugBank) and 73 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 70 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 45 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
mTOR signaling pathway
15 genes, 33 drugs (DrugBank) and 99 diseases
Natural killer cell mediated cytotoxicity
45 genes, 49 drugs (DrugBank) and 91 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 38 diseases
Neutrophil extracellular trap formation
37 genes, 45 drugs (DrugBank) and 78 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Non-small cell lung cancer
21 genes, 39 drugs (DrugBank) and 57 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Pancreatic cancer
20 genes, 43 drugs (DrugBank) and 86 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
Phosphatidylinositol signaling system
5 genes, 6 drugs (DrugBank) and 11 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Progesterone-mediated oocyte maturation
14 genes, 39 drugs (DrugBank) and 47 diseases
Prolactin signaling pathway
20 genes, 44 drugs (DrugBank) and 74 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Proteoglycans in cancer
34 genes, 75 drugs (DrugBank) and 107 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renal cell carcinoma
15 genes, 16 drugs (DrugBank) and 32 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Shigellosis
31 genes, 54 drugs (DrugBank) and 97 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 39 drugs (DrugBank) and 64 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Sphingolipid signaling pathway
32 genes, 56 drugs (DrugBank) and 84 diseases
Spinocerebellar ataxia
18 genes, 30 drugs (DrugBank) and 79 diseases
T cell receptor signaling pathway
35 genes, 58 drugs (DrugBank) and 88 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Type II diabetes mellitus
15 genes, 44 drugs (DrugBank) and 100 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
Viral carcinogenesis
32 genes, 34 drugs (DrugBank) and 60 diseases
Yersinia infection
25 genes, 43 drugs (DrugBank) and 78 diseases
